If you have trouble viewing the newsletter, please click here.

Reminder: We need your opinion!

Recently, the VISUALizE research team sent out a message in which we invited healthcare professionals to participate in our study. We kindly thank all professionals who already responded to this request. For those who have not yet completed our questionnaire, we would like to remind you that we still very much need your feedback!

Why this study is important:

We try to understand how well patients and healthcare professionals understand benefit and risk information of medicines. Understanding the balance between the benefits and the side effects of medicines is important to all patients and healthcare professionals to help them choose the most appropriate medicine.

Benefits and risks can be communicated in many ways, either as written texts or with graphical visualizations. However, at present we do not know which method is most understandable and useful for patients and healthcare professionals.

Who can help?

We are inviting patients and healthcare professionals with expertise in the following disease areas:

  • atrial fibrillation
  • diabetes
  • breast cancer

who speak English, French or Dutch.

Participants can enter a lottery to win an iPad Air!

All healthcare professionals who complete the survey will beenrolled in a lottery, in which the prizebeing offered isan iPad Air. There will be 10 iPads included in the lottery.

  Participate now »

How can you help?

We have launched an online survey, where benefits and side effects of medicines will be presented in several ways. You will be asked to tell us which is the easiest method to understand benefits and risks of medicines and which method is most helpful for making treatment decisions.
The survey will remain online from May to December 2014. On the website you will be asked to create a username and password. The survey, which takes about 30 minutes, can be stopped and restarted at any time.

Who are we?

The survey is part of a scientific study called VISUALizE (Visualizing Uncertainty Among Laypersons and Experts). The study is being conducted under the PROTECT project*, a public-private partnership supported by the Innovative Medicines Initiative (IMI), that aims to strengthen the monitoring of the benefit-risk balance of medicines in Europe.

The research group leading the VISUALizE study includes several members of the PROTECT consortium, namely: the European Medicines Agency, University of Groningen, University of Utrecht, the Danish Medicines Agency, Laser and the pharmaceutical companies Sanofi and Amgen.

*For more information see the PROTECT website at: www.imi-protect.eu

Participate now »